| abstract |
A therapeutic composition and treatment are provided. An anti-osteopontin agent alone and / or in combination with one or more anti-connexin agents, such as one or more anti-connexin polynucleotides, and / or one or more anti-connexin peptides or peptidomimetics and / or Methods and compositions comprising PDGF receptor blockers or antagonists for promoting and / or improving wound healing and / or tissue repair, and anti-scarring indications, anti-inflammatory indications, anti-fibrotic indications, and anti-adhesion Provided for adaptation. [Selection figure] None |